Metformin ameliorates BSCB disruption by inhibiting neutrophil infiltration and MMP‐9 expression but not direct TJ proteins expression regulation

Blood‐spinal cord barrier (BSCB) disruption is a major process for the secondary injury of spinal cord injury (SCI) and is considered to be a therapeutic target for SCI. Previously, we demonstrated that metformin could improve functional recovery after SCI; however, the effect of metformin on BSCB i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Cell Mol Med
Autores principales: Zhang, Di, Tang, Qian, Zheng, Gang, Wang, Chenggui, Zhou, Yifei, Wu, Yaosen, Xuan, Jun, Tian, Naifeng, Wang, Xiangyang, Wu, Yan, Xu, Huazi, Zhang, Xiaolei
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5706495/
https://ncbi.nlm.nih.gov/pubmed/28699677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13235
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares